6VP-17534-80396 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-04
Dose 1 — Pfizer-BioNTech
2021-03-25
Registered in v-safe
2021-03-25
Dose 2 — Pfizer-BioNTech
2021-03-27
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-03-28
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-29
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-30
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-31
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-01
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-04-17
Survey response — day 21, dose 2
MedDRA: Myalgia, Rhinorrhoea — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities

Free text: Running nose, mussel pain

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-24
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-04-29
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-05-06
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-06-24
Survey response — 3 months, dose 2
MedDRA: Fatigue, Rhinorrhoea, Somnolence — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Running nose, tired and sleepy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-09-23
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-10-11
Dose 3 — Pfizer-BioNTech
2021-10-11
Health check-in — day 0, dose 3
Feeling: Good · Site: Pain · Fever · Headache · Be unable to work or attend school

Adult check-in
2022-07-08
Dose 4 — Pfizer-BioNTech
2022-07-09
Health check-in — days 1–6 daily, dose 4
Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activities

Adult check-in
2023-01-08
Dose 5 — Pfizer-BioNTech
2023-01-08
Health check-in — 6 months, dose 4
Feeling: Good

Adult check-in
2023-01-09
Health check-in — days 1–6 daily, dose 5
Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activities

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-04	Pfizer-BioNTech
2	2021-03-25	Pfizer-BioNTech
3	2021-10-11	Pfizer-BioNTech	No
4	2022-07-08	Pfizer-BioNTech	No
5	2023-01-08	Pfizer-BioNTech	No

Free text

Release 7 — day 21, dose 2

2021-04-17

Symptoms: Running nose, mussel pain

Release 9 — 3 months, dose 2

2021-06-24

Symptoms: Running nose, tired and sleepy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Fatigue	✓	✓	✓
SD	Myalgia	✓	✓	✓
SD	Rhinorrhoea	✓	✓	✓
SD	Somnolence	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release